VSCOJuly 20, 2026 at 6:47 PM UTCConsumer Discretionary Distribution & Retail

Victoria's Secret Turnaround Gains Recognition; Stock Rallies on CEO Fit and Improving Trends

Read source article

What happened

A recent Barron's article highlights growing investor optimism under CEO Hillary Super, with Morgan Stanley turning positive on the stock's turnaround. The DeepValue report confirms stabilization and execution progress, notably 2024 improvements in sales and profits and Q2 2025 comparable sales up 4% excluding a cyber incident, though margins compressed. However, near-term headwinds persist: tariff-driven cost pressure, intense competition in intimates, and a Q2 operating margin decline to 2.8%. The BUY thesis at ~10.8x P/E relies on sustained comparable sales, remodel ROI, and margin recapture as catalysts for multiple expansion. The narrative is gaining traction, but execution risks and cost headwinds warrant careful monitoring before full conviction.

Implication

The positive press reinforces the turnaround story, but the DeepValue report's caution remains warranted. Early execution under new leadership shows promise—comps improved, international sales grew 11% in 2024, and the balance sheet is solid with $227M cash and no ABL borrowings. However, near-term margin compression from tariffs and the cyber incident, plus intense competition from Aerie and DTC players, mean the bull case is not yet de-risked. Investors should watch for consistent comparable sales growth, gross margin expansion, and remodel productivity to validate the thesis. Until then, the discounted valuation provides a margin of safety, but any earnings disappointment could quickly erode confidence and stall the multiple re-rating.

Thesis delta

The Barron's article and Morgan Stanley's upgraded view provide additional market validation for the turnaround thesis, consistent with our BUY stance. However, the fundamental drivers—margin recovery, PINK momentum, and tariff mitigation—remain unproven at scale. We see no reason to alter our risk-aware BUY recommendation, but we will monitor upcoming quarters for evidence of sustained improvement to either strengthen or invalidate the thesis.

Confidence

Medium